chr3-57198242-CTG-C
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 3P and 0B. PVS1_ModeratePP5
The NM_003865.3(HESX1):c.511_512delCA(p.Gln171fs) variant causes a frameshift change. The variant allele was found at a frequency of 0.0000217 in 1,612,998 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.000026 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000021 ( 0 hom. )
Consequence
HESX1
NM_003865.3 frameshift
NM_003865.3 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 6.14
Genes affected
HESX1 (HGNC:4877): (HESX homeobox 1) This gene encodes a conserved homeobox protein that is a transcriptional repressor in the developing forebrain and pituitary gland. Mutations in this gene are associated with septooptic dysplasia, HESX1-related growth hormone deficiency, and combined pituitary hormone deficiency. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 3 ACMG points.
PVS1
Loss of function variant, product does not undergo nonsense mediated mRNA decay. Variant is located in the 3'-most exon, not predicted to undergo nonsense mediated mRNA decay. Fraction of 0.0842 CDS is truncated, and there are 0 pathogenic variants in the truncated region.
PP5
Variant 3-57198242-CTG-C is Pathogenic according to our data. Variant chr3-57198242-CTG-C is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 197223.We mark this variant Likely_pathogenic, oryginal submissions are: {Uncertain_significance=1, Pathogenic=1}.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HESX1 | ENST00000295934.8 | c.511_512delCA | p.Gln171fs | frameshift_variant | 4/4 | 1 | NM_003865.3 | ENSP00000295934.3 | ||
HESX1 | ENST00000647958.1 | c.511_512delCA | p.Gln171fs | frameshift_variant | 7/7 | ENSP00000498190.1 | ||||
HESX1 | ENST00000473921.2 | c.409_410delCA | p.Gln137fs | frameshift_variant | 3/3 | 5 | ENSP00000418918.1 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152020Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
4
AN:
152020
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000558 AC: 14AN: 251078Hom.: 0 AF XY: 0.0000589 AC XY: 8AN XY: 135754
GnomAD3 exomes
AF:
AC:
14
AN:
251078
Hom.:
AF XY:
AC XY:
8
AN XY:
135754
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000212 AC: 31AN: 1460978Hom.: 0 AF XY: 0.0000220 AC XY: 16AN XY: 726792
GnomAD4 exome
AF:
AC:
31
AN:
1460978
Hom.:
AF XY:
AC XY:
16
AN XY:
726792
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152020Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74246
GnomAD4 genome
AF:
AC:
4
AN:
152020
Hom.:
Cov.:
32
AF XY:
AC XY:
2
AN XY:
74246
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:1Uncertain:1
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Dec 18, 2014 | - - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Oct 10, 2018 | The p.Gln171ValfsExtX8 variant in HESX1 has not been previously reported in indi viduals with septo-optic dysplasia but has been identified in 0.1% (10/9844) of Ashkenazi Jewish chromosomes by gnomAD (http://gnomad.broadinstitute.org). This variant is predicted to cause a frameshift altering the protein?s terminal 14 am ino acids beginning at position 171, abolishing the stop codon, and extending th e protein by 8 amino acids. It is unclear if this alteration will impact the pro tein. In summary, the clinical significance of the p.Gln171ValfsExtX8 variant is uncertain. ACMG/AMP Criteria applied: PM4. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at